
Sleep-Wake Disorders
Latest News

Seltorexant vs Quetiapine: Metabolic Profiles of Participants With MDD and Insomnia Symptoms in Phase 3 Trial
Latest Videos

Shorts
CME Content
More News

Explore the complexities of insomnia treatment, highlighting the limited role of melatonin and the effectiveness of cognitive behavioral therapy for better sleep.

Alixorexton shows promising results in improving wakefulness and reducing daytime sleepiness in patients with narcolepsy type 2.

Explore the complexities of insomnia in older adults, its impact on health, and effective management strategies for improved sleep quality.

Discover the most effective components of cognitive behavioral therapy for chronic insomnia, enhancing treatment outcomes and patient care strategies.

Sleep disruption undermines team coordination in sports, revealing its critical role in collective performance and strategic success.

A new study reveals tasimelteon (Hetlioz) significantly improves sleep onset in chronic insomnia patients.

New phase 3 data reveals seltorexant's potential as a safer adjunctive treatment for major depressive disorder with insomnia, despite not meeting its primary end point.

Cognitive behavioral therapy for insomnia effectively treats chronic insomnia, promoting long-term sleep improvement through targeted behavioral strategies.

Takeda's oveporexton shows promising results in treating narcolepsy type 1, significantly improving symptoms and quality of life in clinical trials.

Alixorexton shows promise as a treatment for narcolepsy type 1, and is the first orexin 2 receptor agonist to demonstrate clinically meaningful and statistically significant impact on wakefulness, cognition, and fatigue with once-daily dosing across a range of doses.

Explore effective strategies for managing narcolepsy, including personalized treatment plans, medication options, and lifestyle interventions for improved patient outcomes.

Discover the complexities of sleep-related eating disorder, its symptoms, triggers, and effective treatments for better sleep health.

Apnimed reveals promising results for AD109, a groundbreaking oral treatment for obstructive sleep apnea.

Positive phase 2 results show that treatment with alixorexton led to statistically significant and dose-dependent improvements in sleep latency among patients with narcolepsy type 1.

What is a sleep disorder? Explore the complexities of their definitions and the impact of circadian rhythms on health and well-being.

Explore the intricate relationship between sleep disorders and psychiatric conditions, diagnostic challenges, and effective management strategies, in this Special Report article.

Explore the complex relationship between insomnia and mental health, and learn more about effective treatments like CBT-I for better sleep and well-being.

There is a critical link between sleep disorders and psychiatric conditions. In this Special Report, examine effective diagnosis and treatment strategies for better patient outcomes.

Hypersomnias are a complex set of sleep disorders. Proper sleep evaluations are crucial for accurate diagnosis.

Effective diagnosis and treatment of comorbid disorders in patients with bipolar enhance care and lead to more optimal mental health outcomes.

Discover the unique approaches to treating sleep disorders in children vs adults, highlighting effective behavioral strategies.


Collaboration in sleep medicine can optimize treatment for conditions like narcolepsy, ADHD, and insomnia.

Collaboration between sleep specialists and mental health providers is critically important for effective treatment of sleep disorders and psychiatric issues.

What is the nature of the intricate relationship between sleep disorders and psychiatric conditions?





















